Eventide Gilead A

Eventide Gilead A

ETAGX
Eventide Gilead AUS flagNASDAQ
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Eventide Gilead Fund Class A (ETAGX) is a diversified mutual fund managed by Eventide Asset Management, LLC that seeks long-term capital appreciation by investing primarily in a broad range of equity securities of companies across market capitalizations, with historical emphases on small- and mid-cap growth stocks in the healthcare, life sciences, and information technology sectors; it employs a thematic investment approach targeting companies positioned for long-term secular trends while prioritizing those that create compelling value for society and the global common good through ethical, sustainable business practices benefiting customers, employees, suppliers, communities, and the environment. The fund offers multiple share classes including Class A (ETAGX, with a 5.75% front-end load and 1.41% net expense ratio), Class I (ETILX), Class C (ETCGX), and Class N (ETGLX), featuring approximately 68 holdings with top positions in innovative firms such as Xometry Inc. (AI-enabled on-demand manufacturing marketplace), Guardant Health Inc. (cell diagnostics for cancer patients), Mirum Pharmaceuticals Inc. (IBAT inhibitors for rare pediatric cholestasis diseases), Toast Inc. (cloud software for restaurants), and Trane Technologies PLC (energy-efficient HVAC systems); sector allocations include technology (31.15%), healthcare (27.22%), industrials (17.81%), and consumer cyclical (10.07%), with primary geographic exposure in the United States (81%) and additional positions in non-U.S. markets including the Middle East, Canada, the United Kingdom, and the Eurozone. Eventide Asset Management, founded in 2008 and headquartered in Boston, Massachusetts, manages the fund with lead portfolio responsibility held by Finny Kuruvilla, MD, PhD, Co-Chief Investment Officer and Senior Portfolio Manager. In recent developments, Eventide celebrated the Eventide Gilead Fund's 15-year anniversary in 2023, highlighting its annualized net return of 13.44% for the N share class since inception through June 2023, outperforming the Russell Midcap Growth Index; the firm expanded its offerings in September 2025 with the launch of three new systematic ETFs—Eventide Large Cap Growth ETF (ESLG), Large Cap Value ETF (ESLV), and Small Cap ETF (ESSC) on NYSE Arca—building on the prior success of the Eventide US Market ETF (ESUM) and incorporating the proprietary Business 360 framework for values-aligned investing; additionally, Eventide received recognition in Pensions & Investments' Best Places to Work in Money Management in late 2025 and updated its advisory strategies in March 2024 to include exchange-traded funds and a new U.S. Equity Market Strategy. The fund, with total net assets of approximately $2.68 billion and share class assets of $290.98 million as of recent data, targets individual and institutional investors seeking non-correlated returns with low market correlation through high internal diversification, and remains available primarily in the United States with a minimum initial investment of $1,000.